Thrivent Financial for Lutherans’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.01M | Buy |
56,412
+11,699
| +26% | +$164K | ﹤0.01% | 1978 |
|
|
2026
Q1 | $421K | Sell |
44,713
-1,317
| -3% | -$14.5K | ﹤0.01% | 2279 |
|
|
2025
Q4 | $572K | Sell |
46,030
-2,308
| -5% | -$30.7K | ﹤0.01% | 2199 |
|
|
2025
Q3 | $693K | Sell |
48,338
-42,938
| -47% | -$588K | ﹤0.01% | 1959 |
|
|
2025
Q2 | $1.12M | Buy |
91,276
+400
| +0.4% | +$5.81K | ﹤0.01% | 1717 |
|
|
2025
Q1 | $2M | Sell |
90,876
-2,551
| -3% | -$60K | ﹤0.01% | 1289 |
|
|
2024
Q4 | $2.12M | Buy |
93,427
+38,597
| +70% | +$842K | ﹤0.01% | 1391 |
|
|
2024
Q3 | $996K | Sell |
54,830
-2,082
| -4% | -$48.3K | ﹤0.01% | 1914 |
|
|
2024
Q2 | $1.66M | Buy |
56,912
+39,868
| +234% | +$1.18M | ﹤0.01% | 1516 |
|
|
2024
Q1 | $604K | Buy |
17,044
+53
| +0.3% | +$2.12K | ﹤0.01% | 2157 |
|
|
2023
Q4 | $740K | Sell |
16,991
-742
| -4% | -$29.2K | ﹤0.01% | 2028 |
|
|
2023
Q3 | $677K | Sell |
17,733
-659
| -4% | -$27.7K | ﹤0.01% | 1986 |
|
|
2023
Q2 | $756K | Sell |
18,392
-4,050
| -18% | -$195K | ﹤0.01% | 1977 |
|
|
2023
Q1 | $1.29M | Sell |
22,442
-178
| -0.8% | -$10K | ﹤0.01% | 1621 |
|
|
2022
Q4 | $1.27M | Sell |
22,620
-3,889
| -15% | -$198K | ﹤0.01% | 1580 |
|
|
2022
Q3 | $1.12M | Sell |
26,509
-10,151
| -28% | -$520K | ﹤0.01% | 1614 |
|
|
2022
Q2 | $1.98M | Sell |
36,660
-277
| -0.7% | -$16.6K | 0.01% | 1236 |
|
|
2022
Q1 | $2.37M | Sell |
36,937
-787
| -2% | -$51.8K | ﹤0.01% | 1220 |
|
|
2021
Q4 | $2.53M | Sell |
37,724
-487
| -1% | -$32.9K | ﹤0.01% | 1235 |
|
|
2021
Q3 | $2.62M | Buy |
38,211
+46
| +0.1% | +$3.25K | 0.01% | 1187 |
|
|
2021
Q2 | $2.6M | Buy |
38,165
+13
| +0% | +$919 | 0.01% | 1249 |
|
|
2021
Q1 | $2.64M | Sell |
38,152
-636
| -2% | -$43.1K | 0.01% | 1229 |
|
|
2020
Q4 | $2.52M | Buy |
38,788
+19,733
| +104% | +$1.06M | 0.01% | 1171 |
|
|
2020
Q3 | $900K | Sell |
19,055
-398
| -2% | -$18.9K | ﹤0.01% | 1631 |
|
|
2020
Q2 | $914K | Buy |
19,453
+831
| +4% | +$40.8K | ﹤0.01% | 1560 |
|
|
2020
Q1 | $832K | Hold |
18,622
| – | – | ﹤0.01% | 1411 |
|
|
2019
Q4 | $1.08M | Buy |
18,622
+190
| +1% | +$11.3K | ﹤0.01% | 1420 |
|
|
2019
Q3 | $1.11M | Sell |
18,432
-269
| -1% | -$16K | ﹤0.01% | 1340 |
|
|
2019
Q2 | $1.04M | Buy |
18,701
+387
| +2% | +$19.9K | ﹤0.01% | 1370 |
|
|
2019
Q1 | $1.02M | Buy |
18,314
+362
| +2% | +$18.4K | ﹤0.01% | 1358 |
|
|
2018
Q4 | $810K | Buy |
17,952
+942
| +6% | +$51.7K | ﹤0.01% | 1296 |
|
|
2018
Q3 | $1.12M | Buy |
17,010
+937
| +6% | +$58.2K | ﹤0.01% | 1200 |
|
|
2018
Q2 | $1.03M | Sell |
16,073
-26,718
| -62% | -$1.65M | ﹤0.01% | 1233 |
|
|
2018
Q1 | $2.37M | Buy |
42,791
+3,517
| +9% | +$184K | 0.01% | 839 |
|
|
2017
Q4 | $1.88M | Buy |
39,274
+774
| +2% | +$37.9K | 0.01% | 938 |
|
|
2017
Q3 | $1.94M | Buy |
38,500
+1,840
| +5% | +$94.5K | 0.01% | 874 |
|
|
2017
Q2 | $2M | Buy |
36,660
+2,880
| +9% | +$138K | 0.01% | 819 |
|
|
2017
Q1 | $1.42M | Buy |
33,780
+1,620
| +5% | +$69.2K | 0.01% | 986 |
|
|
2016
Q4 | $1.38M | Buy |
32,160
+1,720
| +6% | +$69.9K | 0.01% | 997 |
|
|
2016
Q3 | $1.26M | Buy |
30,440
+2,020
| +7% | +$84.6K | 0.01% | 1036 |
|
|
2016
Q2 | $1.13M | Buy |
28,420
+1,900
| +7% | +$68.4K | 0.01% | 1052 |
|
|
2016
Q1 | $893K | Buy |
26,520
+1,600
| +6% | +$49.8K | ﹤0.01% | 1120 |
|
|
2015
Q4 | $845K | Buy |
24,920
+1,420
| +6% | +$44.4K | ﹤0.01% | 1123 |
|
|
2015
Q3 | $700K | Sell |
23,500
-598
| -2% | -$18.7K | ﹤0.01% | 1071 |
|
|
2015
Q2 | $664K | Buy |
24,098
+1,223
| +5% | +$32.6K | ﹤0.01% | 970 |
|
|
2015
Q1 | $576K | Buy |
22,875
+490
| +2% | +$11.6K | ﹤0.01% | 1043 |
|
|
2014
Q4 | $496K | Buy |
22,385
+122
| +0.5% | +$2.47K | ﹤0.01% | 1116 |
|
|
2014
Q3 | $452K | Buy |
22,263
+1,101
| +5% | +$21.9K | ﹤0.01% | 1154 |
|
|
2014
Q2 | $407K | Buy |
21,162
+122
| +0.6% | +$2.27K | ﹤0.01% | 1226 |
|
|
2014
Q1 | $396K | Hold |
21,040
| – | – | ﹤0.01% | 1078 |
|
|
2013
Q4 | $410K | Buy |
21,040
+2,936
| +16% | +$53.9K | ﹤0.01% | 1075 |
|
|
2013
Q3 | $298K | Buy |
18,104
+245
| +1% | +$3.93K | ﹤0.01% | 1224 |
|
|
2013
Q2 | $267K | Buy |
+17,859
| New | +$262K | ﹤0.01% | 1272 |
|
Other funds holding IART
RCMNY
PCMI
Thrivent Financial for Lutherans's IART Position: Q2 2026 in Review
Thrivent Financial for Lutherans increased its Integra LifeSciences (IART) stake by 26% in Q2 2026, buying an estimated $164K and bringing the position to 56,412 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1978.
Thrivent Financial for Lutherans first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.64M in Q1 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Thrivent Financial for Lutherans held 56,412 shares of Integra LifeSciences worth $1.01M as of Q2 2026.
- Thrivent Financial for Lutherans bought 11,699 Integra LifeSciences shares in Q2 2026, an estimated $164K.
- Integra LifeSciences made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1978 holding.
- Thrivent Financial for Lutherans first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Thrivent Financial for Lutherans's Integra LifeSciences position peaked at $2.64M in Q1 2021.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.